PNTG
PNTG
NASDAQ · Health Care

Pennant Group Inc/The

$30.35
+0.37 (+1.23%)
As of Feb 8, 1:42 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -16.9% upside
Low Target $18.01
Average Target $25.22
High Target $35.24
Current Price $30.35
Current
$30.35
Target
$25.22
$18.01 $25.22 avg $35.24
Scenario Analysis
Bear Case
$18.01
-40.7%
Low target
Base Case
$25.22
-16.9%
Avg target
Bull Case
$35.24
+16.1%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$31.94
-5.0% from high
52-Week Low
$21.18
+43.3% from low
Target vs 52W High
$25.22
-21.0% vs high
Next Earnings Report
Feb 25, 2026 · After Market Close
9d
until earnings
EPS Est: $0.32
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%